COMMUNIQUÉS West-GlobeNewswire
-
CooperCompanies Releases 2025 Corporate Sustainability Report with Scope 3 Emissions Disclosure
30/06/2026 -
Cosmos Health Authorizes Up to $5 Million Share Repurchase Program
30/06/2026 -
Travel Fatigue Treatments Gain Traction as Summer Travel Increases, Says Prana IV Therapy
30/06/2026 -
AGC Biologics Expands to Fill-Finish in U.S. Through Strategic Partnership with Pyramid Pharma Services
30/06/2026 -
CBDWatchlist.com Introduces 2026 CBD Gummies and CBD Oil Transparency Review Initiative
30/06/2026 -
Breckenridge Distillery Earns Double Gold for Rum Cask Finish at New York International Spirits Competition
30/06/2026 -
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds
30/06/2026 -
PetMed Express, Inc. Confirms Receipt of Unsolicited, Non-Binding, and Conditional Acquisition Proposal from SilverCape Investments Limited
30/06/2026 -
Adam Ferrari Health Science Scholarship Closes 2026 Application Window
30/06/2026 -
ReFocus Eye Health Partners with Solinsky EyeCare, Expanding its Comprehensive Eye Care Network
30/06/2026 -
Serenity Medical Receives U.S. FDA Breakthrough Device Designation for The Serenity Shepherd Stent™ System to Treat Pulsatile Tinnitus
30/06/2026 -
Arizona Nonprofit Launches "Second Chance" Fundraiser for Custom Lexus LX 700h Overtrail to Benefit Childhood Blindness Research
30/06/2026 -
Applied Biologics Announces National Commercial Expansion to Support Continued Growth of XWRAP® and Future Biologic Product Pipeline
30/06/2026 -
TPN.health Introduces Proprietary Integrated Claims and Credentialing Platform: Resolves Patient Barriers to Behavioral Health Access and Ensures Clinician Payments
30/06/2026 -
Celebrate the Fourth—Without Damaging Your Hearing or Losing Your Voice
30/06/2026 -
SS Innovations Named Outstanding Company Winner at the 2026 Surgical Robotics Industry Awards
30/06/2026 -
Arcutis Launches New Virtual Health Platform Supporting Access to Care for Individuals Living with Chronic Inflammatory Skin Diseases, Including Approved ZORYVE® (roflumilast) Indications
30/06/2026 -
Ally Medical ER Continues Its Austin-Area Growth With Cedar Park Opening
30/06/2026 -
Dogwood Therapeutics Appoints Iain Dukes, Venture Partner at OrbiMed, as Chair of Scientific Advisory Board
30/06/2026
Pages